Detalhe da pesquisa
1.
Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma.
Int J Mol Sci
; 22(14)2021 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299249
2.
Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.
Int J Mol Sci
; 22(14)2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298999
3.
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma.
Cancer
; 125(20): 3603-3614, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251403
4.
The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
Int J Mol Sci
; 18(6)2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28587170
5.
Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.
Int J Mol Sci
; 18(6)2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629173
6.
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation.
Mol Cell Biochem
; 374(1-2): 181-90, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23180246
7.
Numerical Simulation and Experimental Study of Cold and Hot Composite Forming of Sharp-Edged High-Strength Steel Sections.
Materials (Basel)
; 16(21)2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37959590
8.
Effect of Cold and Hot Compounds Forming on Microstructures and Mechanical Properties in the Deformation Zone of Sharp-Edged High-Strength Steel Sections.
Materials (Basel)
; 16(17)2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37687691
9.
Interfacial Characterization and Thermal Conductivity of Diamond/Cu Composites Prepared by Liquid-Solid Separation Technique.
Nanomaterials (Basel)
; 13(5)2023 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36903755
10.
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.
Cancer Metab
; 11(1): 7, 2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226257
11.
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines.
Biochem Biophys Res Commun
; 394(3): 760-6, 2010 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20227389
12.
Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.
Mol Cancer Res
; 18(1): 105-117, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628200
13.
Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins.
Eur J Pharmacol
; 591(1-3): 124-7, 2008 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18585380
14.
The dual effects of a novel peptibody on angiogenesis inhibition and M2 macrophage polarization on sarcoma.
Cancer Lett
; 416: 1-10, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29104145
15.
Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation.
Mol Oncol
; 11(12): 1806-1825, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094484
16.
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Oncotarget
; 8(30): 49275-49292, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525376
17.
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
Oncotarget
; 7(14): 17665-80, 2016 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771234
18.
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy.
Oncotarget
; 7(26): 40437-40450, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27250027
19.
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.
Mol Cancer
; 4(1): 25, 2005 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16033649
20.
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.
Oncotarget
; 6(8): 6295-309, 2015 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25749046